{"id":2143,"date":"2011-12-14T00:00:00","date_gmt":"2011-12-14T08:00:00","guid":{"rendered":"https:\/\/vermont.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/"},"modified":"2023-12-11T14:02:46","modified_gmt":"2023-12-11T22:02:46","slug":"alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression","status":"publish","type":"disclosure","link":"https:\/\/www.salk.edu\/zh\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/","title":{"rendered":"\u963f\u5c14\u8328\u6d77\u9ed8\u75c5\u5019\u9009\u836f\u7269\u53ef\u80fd\u6210\u4e3a\u9996\u4e2a\u80fd\u963b\u6b62\u75be\u75c5\u8fdb\u5c55\u7684\u836f\u7269"},"content":{"rendered":"<p>LA JOLLA, CA\u2014A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published in <em>PLoS ONE<\/em>.\r\n<\/p><p>\r\nWhen given to mice with Alzheimer's, the drug, known as J147, improved memory and prevented brain damage caused by the disease. The new compound, developed by scientists at the Salk Institute for Biological Studies, could be tested for treatment of the disease in humans in the near future.\r\n<\/p><iframe src=\"https:\/\/www.youtube.com\/embed\/xz_0zujJjD0?rel=0\" frameborder=\"0\" allowfullscreen><\/iframe><p>\r\n\"J147 enhances memory in both normal and Alzheimer's mice and also protects the brain from the loss of synaptic connections,\" says <a href=\"\/zh\/faculty\/schubert.html\/\">David Schubert<\/a>, the head of Salk's Cellular Neurobiology Laboratory, whose team developed the new drug. \"No drugs on the market for Alzheimer's have both of these properties.\"\r\n<\/p><p>\r\nAlthough it is yet unknown whether the compound will prove safe and effective in humans, the Salk researchers' say their results suggest the drug may hold potential for treatment of people with Alzheimer's.\r\n<\/p><p>\r\nAs many as 5.4 million Americans suffer from Alzheimer's, according to the National Institutes of Health. More than 16 million will have the disease by 2050, according to <a href=\"http:\/\/www.alz.org\">Alzheimer's Association<\/a> estimates, resulting in medical costs of over $1 trillion per year.\r\n<\/p><div class=\"imageCaption\"><img decoding=\"async\" src=\"https:\/\/www.salk.edu\/wp-content\/uploads\/2011\/01\/532-schubert.jpg\" alt=\"J147\" width=\"300\"><p>Salk scientists develop J147, a synthetic drug shown to improve memory and prevent brain damage in mice with Alzheimer's disease. <\/p><p>Image: Courtesy of Salk Institute for Biological Studies<\/p><\/div>\r\n<p>\r\nThe disease causes a steady, irreversible decline in brain function, erasing a person's memory and ability to think clearly until they are unable to perform simple tasks such as eating and talking, and it is ultimately fatal. Alzheimer's is linked to aging and typically appears after age 60, although a small percentage of families carry a genetic risk for earlier onset. Among the top ten causes of death, Alzheimer's is the only one without a way to prevent, cure or slow down disease progression.\r\n<\/p><p>\r\nScientists are unclear what causes Alzheimer's, which appears to emerge from a complex mix of genetics, environment and lifestyle factors. So far, the drugs developed to treat the disease, such as Aricept, Razadyne and Exelon, only produce fleeting memory improvements and do nothing to slow the overall course of the disease.\r\n<\/p><p>\r\nTo find a new type of drug, Schubert and his colleagues bucked the trend within the pharmaceutical industry of focusing exclusively on the biological pathways involved in the formation of amyloid plaques, the dense deposits of protein that characterize the disease. To date, Schubert says, all amyloid-based drugs have failed in clinical trials.\r\n<\/p><p>\r\nInstead, the Salk team developed methods for using living neurons grown in laboratory dishes to test whether or not new synthetic compounds were effective at protecting the brain cells against several pathologies associated with brain aging. Based on the test results from each chemical iteration of the lead compound, which was originally developed for treatment of stroke and traumatic brain injury, they were able to alter its chemical structure to make a much more potent Alzheimer's drug.\r\n<\/p><p>\r\n\"Alzheimer's is a complex disease, but most drug development in the pharmaceutical world has focused on a single aspect of the disease--the amyloid pathway,\" says Marguerite Prior, a research associate in Schubert's lab, who led the project along with Qi Chen, a former Salk postdoctoral researcher. \"In contrast, by testing these compounds in living cell cultures, we can determine what they do against a range of age-related problems and select the best candidate that addresses multiple aspects of the disease, not just one.\"\r\n<\/p><p>\r\nWith a promising compound in hand, the researchers shifted to testing J147 as an oral medication in mice. Working with Amanda Roberts, a professor of molecular neurosciences at The Scripps Research Institute, they conducted a range of behavioral tests that showed that the drug improved memory in normal rodents.\r\n<\/p><p>\r\nThe Salk researchers went on to show that it prevented cognitive decline in animals with Alzheimer's and that mice and rats treated with the drug produced more of a protein called brain-derived neurotrophic factor (BDNF), a molecule that protects neurons from toxic insults, helps new neurons grow and connect with other brain cells, and is involved in memory formation.\r\n<\/p><p>\r\nBecause of the broad ability of J147 to protect nerve cells, the researchers believe that it may also be effective for treating other neurological disorders, such as Parkinson's disease, Huntington's disease and amyotrophic lateral sclerosis (ALS), as well as stroke.            \r\n<\/p><p>\r\nThe research was funded by the Fritz B. Burns Foundation, the National Institutes of Health, the Bundy Foundation and the Alzheimer's Association.\r\n<\/p><p><strong>\r\nAbout the Salk Institute for Biological Studies:<\/strong><br \/>\r\nThe Salk Institute for Biological Studies is one of the world's preeminent basic research institutions, where internationally renowned faculty probe fundamental life science questions in a unique, collaborative, and creative environment. Focused both on discovery and on mentoring future generations of researchers, Salk scientists make groundbreaking contributions to our understanding of cancer, aging, Alzheimer's, diabetes and infectious diseases by studying neuroscience, genetics, cell and plant biology, and related disciplines.\r\n<\/p><p>\r\nFaculty achievements have been recognized with numerous honors, including Nobel Prizes and memberships in the National Academy of Sciences. Founded in 1960 by polio vaccine pioneer Jonas Salk, M.D., the Institute is an independent nonprofit organization and architectural landmark.<\/p>\r\n<p><strong>For more information:<\/strong><br \/>\r\n<em>PLoS ONE<\/em><br \/>\r\nAuthors: Qi Chen, Marguerite Prior, Richard Dargusch, Amanda Roberts, Roland Riek, Cedric Eichmann, Chandramouli Chiruta, Tatsuhiro Akaishi, Kazuho Abe, Pamela Maher, David Schubert<br \/>\r\n<a href=\"http:\/\/http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0027865\">A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease<\/a><\/p>","protected":false},"featured_media":0,"template":"","faculty":[113],"disease-research":[127,146,124,460],"class_list":["post-2143","disclosure","type-disclosure","status-publish","hentry","faculty-dave-schubert","disease-research-alzheimers-disease","disease-research-aging-and-regenerative-medicine","disease-research-neuroscience-and-neurological-disorders","disease-research-traumatic-brain-injury"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Alzheimer&#039;s drug candidate may be first to prevent disease progression - Salk Institute for Biological Studies<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.salk.edu\/zh\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/\" \/>\n<meta property=\"og:locale\" content=\"zh_CN\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Alzheimer&#039;s drug candidate may be first to prevent disease progression - Salk Institute for Biological Studies\" \/>\n<meta property=\"og:description\" content=\"LA JOLLA, CA\u2014A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer&#039;s disease, based on the findings of a study published in PLoS ONE.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.salk.edu\/zh\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/\" \/>\n<meta property=\"og:site_name\" content=\"Salk Institute for Biological Studies\" \/>\n<meta property=\"article:modified_time\" content=\"2023-12-11T22:02:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk-institute-preview-image.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"628\" \/>\n\t<meta property=\"og:image:height\" content=\"329\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"5 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/\",\"name\":\"Alzheimer's drug candidate may be first to prevent disease progression - Salk Institute for Biological Studies\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2011\\\/01\\\/532-schubert.jpg\",\"datePublished\":\"2011-12-14T08:00:00+00:00\",\"dateModified\":\"2023-12-11T22:02:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/#breadcrumb\"},\"inLanguage\":\"zh-CN\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2011\\\/01\\\/532-schubert.jpg\",\"contentUrl\":\"https:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2011\\\/01\\\/532-schubert.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/news-release\\\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.salk.edu\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Alzheimer&#8217;s drug candidate may be first to prevent disease progression\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#website\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"name\":\"Salk Institute for Biological Studies\",\"description\":\"The Power of Science\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.salk.edu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"zh-CN\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#organization\",\"name\":\"Salk Institute for Biological Studies\",\"url\":\"https:\\\/\\\/www.salk.edu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"zh-CN\",\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"contentUrl\":\"http:\\\/\\\/www.salk.edu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/salk_logo_696.jpg\",\"width\":696,\"height\":696,\"caption\":\"Salk Institute for Biological Studies\"},\"image\":{\"@id\":\"https:\\\/\\\/www.salk.edu\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Alzheimer's drug candidate may be first to prevent disease progression - Salk Institute for Biological Studies","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.salk.edu\/zh\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/","og_locale":"zh_CN","og_type":"article","og_title":"Alzheimer's drug candidate may be first to prevent disease progression - Salk Institute for Biological Studies","og_description":"LA JOLLA, CA\u2014A new drug candidate may be the first capable of halting the devastating mental decline of Alzheimer's disease, based on the findings of a study published in PLoS ONE.","og_url":"https:\/\/www.salk.edu\/zh\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/","og_site_name":"Salk Institute for Biological Studies","article_modified_time":"2023-12-11T22:02:46+00:00","og_image":[{"width":628,"height":329,"url":"https:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk-institute-preview-image.jpg","type":"image\/jpeg"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"5 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/","url":"https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/","name":"Alzheimer's drug candidate may be first to prevent disease progression - Salk Institute for Biological Studies","isPartOf":{"@id":"https:\/\/www.salk.edu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/#primaryimage"},"image":{"@id":"https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/#primaryimage"},"thumbnailUrl":"https:\/\/www.salk.edu\/wp-content\/uploads\/2011\/01\/532-schubert.jpg","datePublished":"2011-12-14T08:00:00+00:00","dateModified":"2023-12-11T22:02:46+00:00","breadcrumb":{"@id":"https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/#breadcrumb"},"inLanguage":"zh-CN","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/"]}]},{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/#primaryimage","url":"https:\/\/www.salk.edu\/wp-content\/uploads\/2011\/01\/532-schubert.jpg","contentUrl":"https:\/\/www.salk.edu\/wp-content\/uploads\/2011\/01\/532-schubert.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/www.salk.edu\/news-release\/alzheimers-drug-candidate-may-be-first-to-prevent-disease-progression\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.salk.edu\/"},{"@type":"ListItem","position":2,"name":"Alzheimer&#8217;s drug candidate may be first to prevent disease progression"}]},{"@type":"WebSite","@id":"https:\/\/www.salk.edu\/#website","url":"https:\/\/www.salk.edu\/","name":"\u7d22\u5c14\u514b\u751f\u7269\u7814\u7a76\u6240","description":"The Power of Science","publisher":{"@id":"https:\/\/www.salk.edu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.salk.edu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"zh-CN"},{"@type":"Organization","@id":"https:\/\/www.salk.edu\/#organization","name":"\u7d22\u5c14\u514b\u751f\u7269\u7814\u7a76\u6240","url":"https:\/\/www.salk.edu\/","logo":{"@type":"ImageObject","inLanguage":"zh-CN","@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/","url":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","contentUrl":"http:\/\/www.salk.edu\/wp-content\/uploads\/2023\/03\/salk_logo_696.jpg","width":696,"height":696,"caption":"Salk Institute for Biological Studies"},"image":{"@id":"https:\/\/www.salk.edu\/#\/schema\/logo\/image\/"}}]}},"ACF":{"paper_url":"http:\/\/www.plosone.org\/article\/info%3Adoi%2F10.1371%2Fjournal.pone.0027865","journal_title":"PLOS ONE","paper_author_list":"Qi Chen, Marguerite Prior, Richard Dargusch, Amanda Roberts, Roland Riek, Cedric Eichmann, Chandramouli Chiruta, Tatsuhiro Akaishi, Kazuho Abe, Pamela Maher, David Schubert","paper_title":"A Novel Neurotrophic Drug for Cognitive Enhancement and Alzheimer's Disease","subhead":"Salk scientists develop new drug that improves memory and prevents brain damage in mice","home_photo":"2011\/532-SchubertPriorHeadshot.jpg","listing_photo":"532.jpg","gallery":false,"legacy_boilerplate":[],"doi":"","hide_boilerplate":[],"disable_date":false,"listing_excerpt":"","descriptive_blurb":"","has_journal_cover":false,"og_image_override":false},"_links":{"self":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure\/2143","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure"}],"about":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/types\/disclosure"}],"version-history":[{"count":1,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure\/2143\/revisions"}],"predecessor-version":[{"id":45193,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disclosure\/2143\/revisions\/45193"}],"wp:attachment":[{"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/media?parent=2143"}],"wp:term":[{"taxonomy":"faculty","embeddable":true,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/faculty?post=2143"},{"taxonomy":"disease-research","embeddable":true,"href":"https:\/\/www.salk.edu\/zh\/wp-json\/wp\/v2\/disease-research?post=2143"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}